NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
In recent years, more attention has been focused on Th17 cells that synthesize interleukin-17 (IL-17) in contrast to Th1 and Th2 cells, the marker cytokines of which are interferon-γ (IFN-γ) and IL-4, respectively. It is precisely these pathological activation and expansion of Th17 cells that are su...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2017-03-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2341 |